Total Funding
49
49
Total FundingPrivate Equity raised
Growth Score 49 in past quarter
-2 pts
Heat Score 49 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
54837
Gamma Biosciences is a next-generation bioprocessing for advanced therapies by acquiring or investing in high-potential businesses.
Philip Vanek: Chief Technology OfficerPast Role: GE Healthcare, GM Cell and Gene Therapy Strategy- Matthew Gunnison: PresidentPast Role: General Electric, Head of Corporate Development
About the Company
Gamma Biosciences is an innovator in life sciences focused on bioprocessing tools and technologies for the development and production of advanced therapies, including vaccines, biologics and cell and gene therapies.